NF1 and neoplasm: Functional studies indicate that miR-27a/b also enhances angiogenesis and chemoresistance in tumor cells, making these miRNAs promising candidates for therapeutic targeting aimed at restoring NF1 levels and reducing tumor aggressiveness [52].